For details regarding exhibiting at ACI 2018, please contact ACI@millbrookconferences.co.uk
Exhibition Floor Plan
To download a copy of the exhibition floor plan, please use the link below.Download
File size: 196.86 Kb
PIONEERING VASCULAR SOLUTIONS
From essential vascular devices to next-generation technologies, our products are helping lay the foundation for better health outcomes every day. Minimally invasive treatments help speed recovery and let people get back to their daily activities faster with fewer complications, allowing healthier lives for millions of people worldwide.
We’re dedicated to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education. We have an industry-leading pipeline and comprehensive portfolio of products for cardiac and vascular care. And we’re committed to developing innovative technologies that have the potential to change the way physicians treat vascular disease.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Boston Scientific’s Interventional Cardiology division provides technologies for diagnosing and treating coronary artery disease, structural heart diseases and other cardiovascular disorders.
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations, and the burden of chronic disease — faced by families and healthcare systems today. But, we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com
Cordis is a leader in the development and manufacture of interventional technology with more than 50-years of delivering pioneering products to treat millions of patients worldwide.
We look forward to meeting you to discuss latest updates on the portfolio under Cardinal Health including the Railway Sheathless Access system, and two new distribution agreements with Biosensors & Kaneka that enables Cordis to sell coronary stents under the name LUMENO™ and Kaneka’s PTCA balloon catheters in EMEA.
Minimising vessel trauma is Terumo’s core objective. Our leading edge TRI access and delivery systems allow cardiologists to perform procedures in a safer, faster and more comfortable way.
Terumo’s comprehensive portfolio includes the Ultimaster ™ Drug-Eluting Stent a range of balloon catheters, Ryujin ™, Accuforce ™ and Tazuna ™. An extensive range of diagnostic catheters, unique microcatheters Finecross ™ & Dual Lumen microcatheter Fineduo ™, Runthrough ™ guidewires and a thrombo-aspiration device Eliminate ™. Not forgetting Terumo’s extensive introducer sheath range including Glidesheath Slender ™
From simple to challenging cases, Terumo’s products deliver outstanding performance.
As the leader in image guided therapy, we are committed to working with healthcare providers to help improve treatment for every patient. Our vision is to provide integrated solutions that advance minimally invasive procedures by helping healthcare providers to decide, guide, treat and confirm the right therapy for the right patient at the point of care. Working together to realize this vision, we can save and improve lives and reduce the total cost of care.
Vascular Perspectives Ltd. specialise in promoting unique and innovative products for use in interventional cardiology. We have representatives working throughout the United Kingdom who provide high-level sales and educational support for clinical teams. We believe education is a critical component that allows clinicians to make the correct equipment choice to maximise procedural success. Working with key opinion leaders to communicate new ideas and techniques, we design informative educational programmes to support both products and procedures.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory & Autoimmunity, Cardiovascular & Metabolic Diseases, and Oncology. The company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.co.uk
Biosensors International aims to improve patients’ lives through pioneering medical technology.
Featuring our proprietary anti-restenotic drug Biolimus A9™, polymer and carrier free BioFreedom™ is the only commercially available stent approved for ultra-short 1 month DAPT in HBR patients.
A proven solution* enabling tailored DAPT to meet individual patients’ needs, down to 1 month.
(*LEADERS FREE clinical trial (NEJM October 26th 2015))
Biomatrix Neoflex™ DES, Biomatrix Alpha™ DES and Biostream DEB complete our portfolio.
SMT is a leading developer and manufacturer of minimally invasive coronary stent systems. We have a strong international presence with global footprints in more than 50 countries with proven Safety & Efficacy
SMT is the First company in the world to receive the CE certification for DES with biodegradable polymers which became a ‘trend’ thereafter.
To expand and focus in the European market, SMT now has its European headquarters in Galway with a full fledged R&D centre in addition to the Drug Kinetics and Design R&D operations in India.
The HeartFlow® FFRCT Analysis is the first available non-invasive solution that enables clinicians to evaluate whether an individual has significant coronary artery disease based on both anatomy and physiology. Using data from a standard CT scan, the HeartFlow Analysis creates a personalized 3D model of the coronary arteries and analyzes the impact that blockages have on blood flow. The HeartFlow FFRCT Analysis is recommended by NICE for patients with stable recent onset chest pain.
Merit Medical Systems, Inc. offers an extensive portfolio of innovative products designed to support procedures for treatment of coronary and peripheral vascular disease from start to finish. Meet us at booth #22 and discover the SwiftNINJA® Steerable Coronary Microcatheter, the most advanced and first 180° articulating coronary and peripheral vascular microcatheter on the market today.
ACIST is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange FFR and High Definition IVUS systems. We are also a global market leader in advanced contrast imaging systems for cardiovascular angiography with the CVi Contrast Injection System.
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
CardioLogic Ltd is expanding its interventional portfolio:
Meril’s Sirolimus eluting Biomime and Biomime Morph tapered stents for long and diffuse lesions.
The new Bentley BeGraft 5 French and Guideliner compatible covered stent system for aneurism, perforation and rupture.
The Cellaegis AutoRIC remote ischaemic conditioning system for improved outcomes in your STEMI cases.
BCIS Welcomes New Companies